Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
7.94
+0.12 (1.53%)
Oct 20, 2025, 3:55 PM EDT
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 10.74 billion EUR in the quarter ending June 30, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to 46.17 billion, down -1.99% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61 billion, down -2.16%.
Revenue (ttm)
46.17B EUR
Revenue Growth
-1.99%
P/S Ratio
0.58
Revenue / Employee
502.63K EUR
Employees
91,864
Market Cap
31.43B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
Nuo Therapeutics | 1.95M |
Northwest Biotherapeutics | 1.09M |
Bayer Aktiengesellschaft News
- 11 days ago - BAYRY Begins Phase I Study With KQB548 in KRAS-Mutated Cancers - Nasdaq
- 11 days ago - Why Bayer's Worst Years Might Be The Start Of Its Comeback - Seeking Alpha
- 12 days ago - 3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal - Nasdaq
- 13 days ago - Hesperos and Bayer Consumer Health Develop First Human-on-a-Chip® Model of Stress-Induced Cognitive Dysfunction - Business Wire
- 13 days ago - Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest - Business Wire
- 13 days ago - One A Day® Unveils Bold New Brand Identity and Platform: "The ONE for you" - Benzinga
- 17 days ago - Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV - GlobeNewsWire
- 20 days ago - IPG Wins Bayer’s $720M Global Consumer Health Account - Adweek